E-LIB Suche - Ergebnisse für: Aisner, Dara L.

1

The Efficacy and Safety of Treating Acquired MET Resistance..:

Patil, Tejas ; Staley, Alyse ; Nie, Yunan...
JTO Clinical and Research Reports. 5 (2024) 2 - p. 100637 , 2024

Link: https://doi.org/10.1016/..

2

Characteristics of long-term survivors with EGFR mutant (EG..:

Tompkins, William ; Grady, Connor B. ; Hwang, Wei-Ting...
JTO Clinical and Research Reports. , 2024

Link: https://doi.org/10.1016/..

3

CSF Cytology Identifies Mechanisms of Tyrosine Kinase Inhib..:

Jurica, James M. ; Carsten, Billie ; Balakhani, Sudabeh...
Clinical Lung Cancer. 25 (2024) 1 - p. 77-79 , 2024

Link: https://doi.org/10.1016/..

4

Evolución de la resistencia adquirida en CPNM ROS1+ KRAS G1..:

Priest, Katherine ; Le, Anh ; Gebregzabheir, Amanuail...
Kompass Neumología. 5 (2023) 2 - p. 68-75 , 2023

Link: https://doi.org/10.1159/..

5

Current clinical practices and challenges in molecular test..:

Lee, Thomas D. ; Aisner, Dara L. ; David, Marjorie P....
Blood Advances. 7 (2023) 16 - p. 4599-4607 , 2023

Link: https://doi.org/10.1182/..

6

Think Quik: Successful, Routine Use of Cytology Specimens i..:

Gandara, Elena N. ; Smith, Lynelle ; Guimaraes-Young, Amy.
Journal of the American Society of Cytopathology. 12 (2023) 5 - p. S8-S9 , 2023

Link: https://doi.org/10.1016/..

7

Features of tumor-microenvironment images predict targeted ..:

Wang, Shidan ; Rong, Ruichen ; Yang, Donghan M....
Journal of Clinical Investigation. 133 (2023) 2 - p. , 2023

Link: https://doi.org/10.1172/..

8

Evolution of acquired resistance in a ROS1+ KRAS G12C+ NSCL..:

Priest, Katherine ; Le, Anh ; Gebregzabheir, Amanuail...
npj Precision Oncology. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

9

The Genomics Organization for Academic Laboratories (GOAL):..:

Aisner, Dara L. ; Gocke, Christopher D. ; Jones, Daniel...
Academic Pathology. 10 (2023) 3 - p. 100090 , 2023

Link: https://doi.org/10.1016/..

10

Evolution of acquired resistance in a ROS1+ KRAS G12C+ NSCL..:

Katherine Priest ; Anh Le ; Amanuail Gebregzabheir...
https://doi.org/10.1038/s41698-023-00349-0. , 2023

Link: https://doi.org/10.1038/..

11

Evolution of acquired resistance in a ROS1(+) KRAS G12C(+) ..:

Priest, Katherine ; Le, Anh ; Gebregzabheir, Amanuail...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871013/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Current clinical practices and challenges in molecular test..:

Lee, Thomas D ; Aisner, Dara L ; David, Marjorie P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425685/. , 2023

Link: http://www.ncbi.nlm.nih...

13

The Genomics Organization for Academic Laboratories (GOAL):..:

Aisner, Dara L ; Gocke, Christopher D ; Jones, Daniel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424130/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Features of tumor-microenvironment images predict targeted ..:

Shidan Wang ; Ruichen Rong ; Donghan M. Yang...
https://doi.org/10.1172/JCI160330. , 2023

Link: https://doaj.org/article..

15

Molecular Evidence for Epithelial Origin of Mixed Ovarian E..:

Hall, Katie C. ; Post, Miriam D. ; Alldredge, Jill..
International Journal of Gynecological Pathology. 42 (2022) 4 - p. 403-413 , 2022

Link: https://doi.org/10.1097/..